吸毒人员庚型肝炎病毒感染与吸毒方式、性行为特点关系的研究  

A Study on the Association Between Drug Use Methods, Sexual Behavior Characteristics and Hepatitis G Infection

作　　者：霍梅 李登清[2] 黄民主[3] 关岚[3] 刘浩[3] 何林 

机构地区：[1]深圳市人民医院,广东深圳518020 [2]中南大学医学技术与情报学院检验系 [3]中南大学公共卫生学院

出　　处：《实用预防医学》2005年第2期315-316,共2页Practical Preventive Medicine

摘　　要：目的　了解吸毒人员庚型肝炎病毒(HGV)感染状况与吸毒方式、性行为特点的关系。　方法　采用现况研究,通过整群抽样,随机抽取某男性戒毒所和某女性戒毒所中的吸毒人员,以问卷的方式调查吸毒人员5 95名,收集有关的资料并采集血标本,用酶联免疫吸附试验(ELISA)检测血清中HGV抗体(IgG ) ,采用Chi-square检验对数据进行统计分析。　结果　吸毒人员HGV感染率为8.7% ;注射吸毒组与非注射吸毒组HGV感染率分别为9.5 9%和7.3 9% ,两组间HGV感染率差异无显著性(P >0 .0 5 ) ;有婚外性行为和无婚外性行为的吸毒人员HGV感染率分别为8.8%和8.6% ,两者差异无显著性(P >0 .0 5 ) ;不同性伙伴个数HGV感染率无显著性差异(P >0 .0 5 )。　结论　吸毒人员是感染HGV的高危人群,吸毒方式、性行为特点与HGV感染无显著相关。Objective To investigate the prevalence of HGV infection and its association between drug use route, sexual behavior characteritic and HGV infection in Hunan Province. Methods General information of 595 cases from male and female drug abuser' rehabilitation treatment centers through cluster-sampling and questionnaire forms were completed. Their serums were collected and anti-HGV(IgG) were detected by using ELISA method. Data were analyzed by using Chi-square test. Results Total prevalence of HGV infection was 8.7%. The prevalence of HGV infection among parenteral drug users and non-parenteral drug users was 9.59% and 7.39% respectively,no significant difference was existed (P>0.05). The prevalence of HGV infection among those with or without a history of extramarital sex was 8.8% and 8.6% respectively, also no significant difference between them (P>0.05). The prevalence of HGV infection in groups with different number of sex partners had no significant difference too(P>0.05). Conclusion The drug users are the population at high risk for hepatitis G infection. The prevalence of HGV infection of drug users had no significant relation with drug use route, sexual behavior characteristics, perhaps the lower immunity and lesion induced by the drug were the real reason of HGV infection.

关 键 词：流行病学 吸毒人员 吸毒方式 性行为 庚型肝炎病毒 酶联免疫吸附试验 

分 类 号：R373.21[医药卫生—病原生物学]